News FDA backs Novartis' Gilenya in paediatric MS First disease modifying therapy approved in paediatric MS
News e-Therapeutics and C4XD research Parkinson's drugs Biotechs search for new treatments for incurable disease
News FDA probes Parkinson's drug safety, Acadia's shares collapse FDA under pressure to act following press reports
News Lilly and Alder showcase latest migraine drug data Lilly and Alder take on the might of Novartis and Amgen
News FDA advisers back GW's Epidiolex for rare epilepsy UK firm's potential blockbuster on course for approval
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
